59546 Alternative Splice Variant-Targeted Dendritic Cell Therapy Generates a Systemic Oligoclonal Anti-Tumor Cytotoxic T Cell Response in Diffuse Hemispheric Glioma, H3 G34-Mutant: Early Findings From a First-In-Human Clinical Trial